Spotlight on: Faith Hartley
The National Centre for Asbestos-Related Diseases (NCARD) is proud to spotlight Faith Hartley, whose journey from honours student to PhD researcher demonstrates a strong commitment to improving cancer treatment. Faith…
NCARD expands expertise to transform childhood cancer treatment
The National Centre for Asbestos Related Diseases (NCARD) is bringing its internationally recognised expertise in cancer immunotherapy to improve outcomes for children with cancer. In collaboration with Perth Children’s Hospital…
Why study with NCARD? Listen to the latest podcast on our postgraduate opportunities
Located in Western Australia, home to one of the world’s highest rates of asbestos-related cancers, the National Centre for Asbestos-Related Diseases (NCARD) leads the way in mesothelioma research. At NCARD,…
NCARD study links immune cell types to survival in lung cancer and mesothelioma
Congratulations to Dr Linda Ye, a PhD student at the National Centre for Asbestos Related Diseases (NCARD), along with her supervisors, Associate Professor Alec Redwood, Prof Jenette Creaney and Prof…
NCARD 2024 Annual Scientific Meeting – Public Lecture available online
The 2024 NCARD Annual Scientific Meeting was held on September 18th and 19th at the Harry Perkins Building in QEII Medical Centre. The event included a Public Lecture on the…
Breakthrough research giving new hope for treatment of dust diseases
Through icare, the Dust Diseases Board has funded Dr Alistair Cook’s research over three years endeavouring to create better outcomes for patients who are diagnosed with mesothelioma. Dr Cook was…
Genetically engineered MexTAg mice advance understanding of asbestos-related cancer
At the National Centre of Asbestos Related Diseases (NCARD), we have produced many cutting-edge preclinical tools and models to support our research. These efforts are largely focused on the rare…
Copper-Binding Drugs: A New Approach to Mesothelioma Therapy
The National Centre for Asbestos Related Diseases (NCARD) proudly announces that one of its projects has been awarded funding through the 2024 Cancer Council WA Research Project Grant scheme. This…
Trial increases survival rates for mesothelioma patients
A breakthrough clinical trial has found that combining a new drug with chemotherapy treatment improved survival rates of malignant mesothelioma patients. The study, published in JAMA Oncology, was led by…
World leader in respiratory medicine recognised
An expert in respiratory health at The University of Western Australia has been awarded the Eric Susman Prize for work in the field of Pleural Medicine. Professor Gary Lee, a…